{"id":"placebo-for-ferrous-fumarate","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL1200640","moleculeType":"Small molecule","molecularWeight":"169.90"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Placebo for ferrous fumarate","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T06:53:57.484888+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T06:54:13.623708+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T06:54:03.483435+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Placebo for ferrous fumarate","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T06:54:03.804316+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200640/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T06:54:05.164398+00:00"}},"_dailymed":null,"aiSummary":"Placebo for ferrous fumarate, marketed by Maastricht University Medical Center, holds a niche position in the iron supplement market. The key composition patent is set to expire in 2028, providing a period of exclusivity and potential revenue protection. The primary risk lies in the lack of clear competitive advantages and key trial results, which may limit market adoption and growth.","mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert substances used as controls in clinical trials to measure the effect of an active drug against baseline or psychological expectation. In this case, it serves as a comparator to ferrous fumarate (an iron supplement) in a research study. Any observed effects are attributable to the placebo effect or natural disease course rather than active drug mechanism.","oneSentence":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:51.312Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T06:54:13.623789+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Control arm in ferrous fumarate clinical trial"}]},"trialDetails":[{"nctId":"NCT05682261","phase":"NA","title":"The Effect of Multiple Micronutrient Supplements in Reducing Anemia in Women of Reproductive Age","status":"COMPLETED","sponsor":"Ethiopian Public Health Institute","startDate":"2023-03-23","conditions":"Anemia","enrollment":265},{"nctId":"NCT06869824","phase":"NA","title":"The Efficacy of Minayo Iron-rich Nutritional Gummies on Female Anemia, Skin Condition and Qi-blood Deficiency Syndrome","status":"COMPLETED","sponsor":"Hangzhou Agile Groups Network Technology Co., Ltd.","startDate":"2025-03-17","conditions":"Anemia, Skin Condition, Qi-blood Deficiency Syndrome","enrollment":36},{"nctId":"NCT01656434","phase":"PHASE3","title":"Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2012-11-02","conditions":"Contraception","enrollment":3173},{"nctId":"NCT01975272","phase":"PHASE4","title":"The Use of Iron Therapy for Patients With Anemia After Caesarean Section","status":"TERMINATED","sponsor":"Maastricht University Medical Center","startDate":"2015-03-02","conditions":"Postoperative Anaemia","enrollment":27},{"nctId":"NCT02073149","phase":"PHASE2, PHASE3","title":"Safe and Efficacious Iron for Children in Kenya","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2014-06","conditions":"Anaemia","enrollment":338},{"nctId":"NCT02346188","phase":"NA","title":"Effects of Iron and/or Zinc Supplementation in Mexican School Children Exposed to Lead","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2000-01","conditions":"Lead Poisoning","enrollment":602},{"nctId":"NCT02128971","phase":"PHASE2","title":"A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo","status":"UNKNOWN","sponsor":"Albion","startDate":"2014-04","conditions":"Anemia","enrollment":108},{"nctId":"NCT00999479","phase":"NA","title":"Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation","status":"WITHDRAWN","sponsor":"University of Oklahoma","startDate":"2009-10","conditions":"Endometrioma","enrollment":""},{"nctId":"NCT01634945","phase":"NA","title":"Efficacy of Iron Fortified Complementary Food and IPT of Malaria in Young Children in Côte d'Ivoire","status":"COMPLETED","sponsor":"Swiss Federal Institute of Technology","startDate":"2012-04","conditions":"Anemia","enrollment":629},{"nctId":"NCT00867867","phase":"PHASE1","title":"Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2003-10","conditions":"Healthy Participants, Non-anemic Children, Helicobacter Pylori Infection","enrollment":235}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL1200640"},"_approvalHistory":[],"publicationCount":29,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo tablets"],"phase":"marketed","status":"active","brandName":"Placebo for ferrous fumarate","genericName":"Placebo for ferrous fumarate","companyName":"Maastricht University Medical Center","companyId":"maastricht-university-medical-center","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":1},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T06:54:13.623789+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}